Medical Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% RandomizationBy Marie JonesApril 3, 2024 Clairvoyant on target for potential commercialization of psilocybin treatment in 2025 Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the private clinical-stage pharmaceutical company…
